Acute ischemic syndromes (myocardial infarction, unstable angina) may occur de
novo in previously asymptomatic patients or may occur in the course of
chronic diseases. After hospital-based acute care therapy, with or without percutaneous
or surgical intervention, patients are discharged and receive advice for long-term
therapy. However, some patients develop symptoms again in the short-term course and are
readmitted to the hospital due to clinical as well as non-clinical causes and with
clinical and other non-clinical consequences.[1]Hospital readmissions deserve studies in different settings and have been reported in
medical literature. In one report, the readmission rate after one year in patients older
than 65 years surviving myocardial infarction was 49.9% in 4.767 hospitals in United
States of America between 2008 and 2010; the readmission rate, as well as mortality,
were higher in the first months after discharge and decreased thereafter over 12
months.[2] Additional studies
compared not-for-profit hospitals (15.7%) with proprietary hospitals (16.6%) regarding
readmission rates in the first month of discharge without demonstrating an association
of hospital ownership with the success in programs devoted to decrease readmission rate;
the results of such interventions were not statistically different between the two types
of hospitals.[3] Socioeconomic and ethnic
factors were systemic influences without overt manifestations in a specific
hospital.[4] In many instances,
the readmission rate was studied as a surrogate marker of quality of care;[5-7]
the heterogeneity of patients and medical conditions made a clear association with the
index admission elusive and not easily predicted.[5]In this issue, colleagues from Aracaju (Sergipe, Brazil) report the study[8] of a hospital-based sample of 536
eligible patients with acute coronary syndrome admitted to three private hospitals
(where costs are usually paid by the patient or through an insurance group) and one
public hospital (supported by the government, either city, state or federal government)
to scrutinize variables associated with re-admissions. They observed the readmission
rate was high (115/536, 21.4%) and the mortality of the readmitted patients was also
high - 7%. Acute coronary syndromes and heart failure were the leading causes of
hospital readmission, mainly in patients admitted to private hospital
facilities,[8] probably related
to characteristics of the access. The authors recognize that a hospital-based study
sample without full follow-up data are limitations that may stimulate following the
previous suggestion to remain vigilant[2]
for health deterioration after discharge from in-hospital treatment, emphasizing the
importance of continuous medical advice, support, and therapy. A previous study with a
small sample (Maceió, AL) in the same region of the city of the current study
suggested low adherence of patients to medical therapy as a significant influence on the
frequency of readmissions and mortality.[9]Finally, further studies and interventions are to be stimulated in other cities and
different clinical settings, either hospital-based or at community medical facilities,
taking into consideration local challenges and opportunities to make therapy more
successful by preventing clinical deterioration that need hospital re-admissions after a
period of in-hospital treatment of acute ischemic syndromes.
Authors: Danielle A Southern; Jennifer Ngo; Billie-Jean Martin; P Diane Galbraith; Merril L Knudtson; William A Ghali; Matthew T James; Stephen B Wilton Journal: J Am Heart Assoc Date: 2014-09-18 Impact factor: 5.501
Authors: Kumar Dharmarajan; Angela F Hsieh; Vivek T Kulkarni; Zhenqiu Lin; Joseph S Ross; Leora I Horwitz; Nancy Kim; Lisa G Suter; Haiqun Lin; Sharon-Lise T Normand; Harlan M Krumholz Journal: BMJ Date: 2015-02-05
Authors: Suzanne V Arnold; Kim G Smolderen; Kevin F Kennedy; Yan Li; Supriya Shore; Joshua M Stolker; Tracy Y Wang; Philip G Jones; Zhenxiang Zhao; John A Spertus Journal: J Am Heart Assoc Date: 2015-02-09 Impact factor: 5.501
Authors: Alfredo D Oliveira-Filho; Donald E Morisky; Francisco A Costa; Sara T Pacheco; Sabrina F Neves; Divaldo P Lyra Journal: Arq Bras Cardiol Date: 2014-10-14 Impact factor: 2.000
Authors: Nicholas S Downing; Changqin Wang; Aakriti Gupta; Yongfei Wang; Sudhakar V Nuti; Joseph S Ross; Susannah M Bernheim; Zhenqiu Lin; Sharon-Lise T Normand; Harlan M Krumholz Journal: JAMA Netw Open Date: 2018-09-07